Skip to main content

Table 3 Pre-therapy and post-therapy findings on SRS and SGS in salivary glands

From: Somatostatin receptor scintigraphy in patients with rheumatoid arthritis and secondary Sjögren’s syndrome treated with Infliximab: a pilot study

  Pre-therapy scan Post-therapy scan
  SRS SGS   SRS SGS
Patient n Global score Functional score n Global score Functional score
1 4 6 7.5 3 3 7.5
3 2 2 5 5 2 2.5
4 2 2 4.5 2 2 4.4
5 1 1 5.4 1 1 6.3
6 0 0 6.2 0 0 6.3
7 0 0 5.2 0 0 6.1
8 2 4 5.7 2 2 6.5
9 0 0 6.5 0 0 6.7
12 0 0 7.6 0 0 7.4
14 0 0 6.2 0 0 6.4
18 2 4 5.8 2 3 5.9
Mean 1.18 1.73 5.96 1.09* 1.18* 6.23*
±SD 1.33 2.1 0.97 1.14 1.25 0–91
  1. Table shows values of the number of positive joints (n), of the global score and of the functional score in the salivary glands of the 11 patients that performed somatostatin receptor scintigraphy (SRS) before and after treatment with infliximab
  2. *p = n.s. vs pre-therapy values